Mission of the Department of Medicinal Chemistry
Education and training of scientists of the highest caliber
Providing future pharmacy practitioners with the basis for understanding the relationship between molecular structure and the therapeutic, dispositional, and toxicological aspects of drug action
Improvement of human health through chemical and biological research
Medicinal Chemistry is a dynamic, multifaceted scientific discipline that is dedicated to the improvement of human health through research that leads to the design and development of safe and effective therapeutic, diagnostic, and environmental agents.
Biosafety/ biosecurity, cancer and neurological drug discovery, chemical neuroscience, chemoprevention and carcinogenesis, combinatorial biosynthesis, computer-aided drug design, drug metabolism, gene therapy, high-throughput screening, immunology, NMR, non-hormonal contraception, peptidomimetics and X-ray crystallography.
Faculty Spotlight: Courtney Aldrich
Dr. Aldrich received a $3.8 million NIH grant for the project "Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis" on which he is the sole PI. Also, his collaborative research was the focus of a LA times article.
Faculty Spotlight: Natalia Tretyakova
Faculty Spotlight: Gunda Georg
The ITDD carries out interdisciplinary research, helps educate the next generation of scientists, and enhances the biomedical research infrastructure by creating opportunities for drug discovery and early pre-clinical drug development.
The U.S. Food and Drug Administration has awarded the National Institute for Pharmaceutical Technology and Education, Inc. (NIPTE) with up to $35M funding for a five-year period. The grant - a continuation of a multimillion-dollar FDA grant held by NIPTE since 2011 - supports scientific projects in various areas of pharmaceutical science and technology, such as improving manufacturing practices, quality of pharmaceutical products and the knowledge base of the scientific community.
The University of Minnesota will join a team of academic institutions, private companies, governmental entities and non-profit organizations across the U.S. as a partner for the newly established National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). NIIMBL, a public-private partnership supported by a $70M investment from the National Institute of Standards and Technology and at least $129M from other participants, aims to transform biopharmaceutical manufacturing in the U.S.
What does it take to get to that moment in a clinic when a doctor gives a patient a compound never before used in modern medicine? The story of Minnelide, an investigational drug for pancreatic cancer patients now in a Phase IA clinical trial at the University of Minnesota, illustrates just how complex and exhilarating that journey can be.
New research from the University of Minnesota College of Pharmacy and Masonic Cancer Center has found that consumption of the root of Piper methysticum, or kava, a plant native to the South Pacific Islands, may prevent the development of tobacco smoke-induced lung cancer.
Make use of the Department's over 50,000 square feet of modern research laboratory space located within the Academic Health Center and the Biomedical Discovery District. Read more about our instrumentation, laboratories, facilities and faculty research.
Student Spotlight: Jian Tang
Student Spotlight: Erik Faber
Erik Faber was selected to receive the 2021 Abul-Hajj/Hanna Exceptional Graduate Student Award in Medicinal Chemistry.